Why Clinical Research ?
Clinical Research is essential to understand disease and make advancements in diagnosis and treatment. New treatments must be rigorously tested to be sure that they are safe and effective for general use. Dr. Armstrong and Richmond ENT have performed over 40 clinical trials evaluating new medications and medical devices. Many of these experiments led to successful FDA approvals and new indications for familiar drugs such as Augmentin, Cipro, Flonase and cocaine (approved as a topical anesthetic for nasal procedures). Other studies have supported the development of traditional endoscopic sinus surgery and balloon sinuplasty. We have performed several studies evaluating new treatments for pediatric ear infections. Recent research protocols have focused on non-surgical treatments to reduce nasal polyps, alleviate nasal drainage, restore hearing, reduce tinnitus, and induce spontaneous healing of eardrum perforations.
How Can I Become Involved?
We are currently enrolling patients in non-surgical clinical trials for chronic sinusitis, nasal allergies, nasal polyps, nasal congestion, postnasal drainage, and eardrum perforations. Please click the currently enrolling studies below for more information. Study-related treatments are free and subjects are paid for their time.
Current Enrollment Opportunities
ANCHOR : Patients 18 or older with nasal polyps.
AROMA: Patients 18 or older who are starting Dupixent for nasal polyps
ASTELLAS : Patients 18-75 years old with a persistent eardrum perforation.
ORCHID : Patients 18-75 years of age with a history of chronic sinusitis with bilateral nasal polyps and asthma.
PARAGON: Patients 18 or older with nasal congestion and runny nose.
Upcoming Enrollment Opportunities
ENLIGHTEN: Patients 18 or older with a history of chronic rhinosinusitis.
Interested in participating in one of our active studies or have questions about a study of interest? Please contact Michaela Bailey at 804-622-3768, or mbailey@richmondent.com to schedule your screening visit today!